EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Sigma-1 Receptor Ligands for CNS Cancer Treatment

Anchalee Prasansuklab, Stephen T Safrany, Sirikalaya Brimson, James M Brimson iD

CNS Drugs · 2025-12 · 39 (12) · 1241-1272

DOI: 10.1007/s40263-025-01223-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift CNS Drugs, online erschienen am 18.09.2025. Verfasst von Anchalee Prasansuklab und 3 weiteren Autor:innen. Beteiligte Einrichtung: College of Public Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand. Hauptthemen laut MEDLINE: Receptors, sigma, Antineoplastic Agents, Central Nervous System Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 275 Literaturangaben. Gefördert von: Ratchadaphisek Somphot Funding for International Research Conference.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of new and effective anticancer drugs remains a significant challenge owing to several factors, including the nonspecific nature of conventional therapies, the tendency of cancer cells to develop multidrug resistance, and the difficulty drugs face in crossing specialized barriers such as the blood-brain barrier (BBB) for cancers affecting the central nervous system (CNS). Repurposing existing, approved drugs for new therapeutic uses presents a promising approach to addressing these challenges at lower costs and in shorter time frames. Sigma receptors, particularly sigma-1, are widely distributed in the CNS and have garnered attention in neurodegeneration and pain research. Despite being overexpressed in many cancers, their potential role in cancer treatment has been largely overlooked. Sigma receptors are appealing therapeutic targets because they regulate cell survival, proliferation, and differentiation. Growing evidence links the sigma-1 receptor to the regulation of autophagy, a critical process in cancer development. Several neuroactive drugs, including haloperidol, rimcazole, fluoxetine, and donepezil, act as sigma receptor ligands and may offer anticancer benefits. This review explores the potential of these drugs for treating cancers, particularly those of the CNS, by examining their autophagic, anticancer, and sigma-receptor activities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, sigmaAntineoplastic AgentsCentral Nervous System NeoplasmsHumansSigma-1 ReceptorLigandsAnimalsAutophagyBlood-Brain Barrier

Substanzen

Receptors, sigmaSigma-1 ReceptorAntineoplastic AgentsLigands

Autor:innen und Institutionen

  • College of Public Health Sciences, Chulalongkorn University, Bangkok, 10330, Thailand.
  • Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, 10330, Thailand.
  • School of Medicine, Keele University, Keele, ST5 5BG, UK.
  • Department of Clinical Microscopy, Faculty of Allied Health Sciences, Chulalongkorn University, 154 Rama 1 Road, Bangkok, 10330, Thailand. sirikalaya.J@chula.ac.th.
  • Natural Products for Neuroprotection and Anti-ageing Research Unit, Chulalongkorn University, Bangkok, 10330, Thailand. jamesmichael.b@chula.ac.th.
  • Research, Innovation and International Affairs, Faculty of Allied Health Sciences, Chulalongkorn University, 154 Rama 1 Road, Bangkok, 10330, Thailand. jamesmichael.b@chula.ac.th.

ORCID-Profile: James M Brimson

Förderung

  • Ratchadaphisek Somphot Funding for International Research Conference

Zitieren

APA

Prasansuklab, A., Safrany, S. T., Brimson, S., & Brimson, J. M. (2025). Sigma-1 Receptor Ligands for CNS Cancer Treatment. CNS Drugs, 39(12), 1241-1272. https://doi.org/10.1007/s40263-025-01223-2

Vancouver

Prasansuklab A, Safrany ST, Brimson S, Brimson JM. Sigma-1 Receptor Ligands for CNS Cancer Treatment. CNS Drugs. 2025;39(12):1241-1272. doi:10.1007/s40263-025-01223-2

BibTeX
@article{Prasansuklab2025,
  author = {Prasansuklab, Anchalee and Safrany, Stephen T and Brimson, Sirikalaya and Brimson, James M},
  title = {Sigma-1 Receptor Ligands for CNS Cancer Treatment},
  journal = {CNS Drugs},
  year = {2025},
  volume = {39},
  number = {12},
  pages = {1241--1272},
  doi = {10.1007/s40263-025-01223-2}
}
Kostenlos starten →